121 – 130 of 216
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Improved 223Ra Therapy with Combination Epithelial Sodium Channel Blockade
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article
-
Mark
Transoral robotic surgery in the management of head and neck squamous cell cancer with unknown primary
(
- Contribution to journal › Article
-
Mark
Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules
(
- Contribution to journal › Article
-
Mark
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
(
- Contribution to journal › Article
-
Mark
Global RNA expression and DNA methylation patterns in primary anaplastic thyroid cancer
(
- Contribution to journal › Article
-
Mark
Test-Retest Reliability of Volume and Local Tissue Water Measurements in Lower Limbs of Healthy Women and Men
(
- Contribution to journal › Article
-
Mark
Patients with cutaneous head and neck melanoma, particularly elderly with more advanced primary tumors, seem to benefit from initial CT staging before considering a sentinel lymph node biopsy
(
- Contribution to journal › Article
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181(
- Contribution to journal › Article